Beta-blockers and Breast Cancer-Letter

Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1765. doi: 10.1158/1055-9965.EPI-21-0527.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors
  • Breast Neoplasms* / drug therapy
  • Female
  • Humans

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors